Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trial.
Shulman M, Provost S, Ohrtman K, Novo P, Meyers-Ohki S, Van Veldhuisen P, Oden N, Otterstatter M, Bailey GL, Liu D, Rotrosen J, Nunes EV, Weiss RD. Shulman M, et al. Among authors: nunes ev. Contemp Clin Trials. 2024 Apr 23;142:107543. doi: 10.1016/j.cct.2024.107543. Online ahead of print. Contemp Clin Trials. 2024. PMID: 38657730
Optimizing Contingency Management with Reinforcement Learning.
Kim YG, Brandt L, Cheung K, Nunes EV, Roll J, Luo SX, Liu Y. Kim YG, et al. Among authors: nunes ev. medRxiv [Preprint]. 2024 Mar 29:2024.03.28.24305031. doi: 10.1101/2024.03.28.24305031. medRxiv. 2024. PMID: 38585900 Free PMC article. Preprint.
Rapid Initiation of Injection Naltrexone for Opioid Use Disorder: A Stepped-Wedge Cluster Randomized Clinical Trial.
Shulman M, Greiner MG, Tafessu HM, Opara O, Ohrtman K, Potter K, Hefner K, Jelstrom E, Rosenthal RN, Wenzel K, Fishman M, Rotrosen J, Ghitza UE, Nunes EV, Bisaga A. Shulman M, et al. Among authors: nunes ev. JAMA Netw Open. 2024 May 1;7(5):e249744. doi: 10.1001/jamanetworkopen.2024.9744. JAMA Netw Open. 2024. PMID: 38717773 Free PMC article. Clinical Trial.
Individual-Level Risk Prediction of Return to Use During Opioid Use Disorder Treatment.
Luo SX, Feaster DJ, Liu Y, Balise RR, Hu MC, Bouzoubaa L, Odom GJ, Brandt L, Pan Y, Hser YI, VanVeldhuisen P, Castillo F, Calderon AR, Rotrosen J, Saxon AJ, Weiss RD, Wall M, Nunes EV. Luo SX, et al. Among authors: nunes ev. JAMA Psychiatry. 2024 Jan 1;81(1):45-56. doi: 10.1001/jamapsychiatry.2023.3596. JAMA Psychiatry. 2024. PMID: 37792357
Secondary Analysis of Agreement Between Negative Timeline Follow Back Report and Negative Urine Toxicology in a Large Trial of Individuals with Opioid Use Disorder.
Shulman M, Choo TH, Scodes J, Pavlicova M, Novo P, Campbell ANC, Greiner M, Lee JD, Rotrosen J, Nunes EV. Shulman M, et al. Among authors: nunes ev. J Addict Med. 2023 Sep-Oct 01;17(5):618-620. doi: 10.1097/ADM.0000000000001173. Epub 2023 May 17. J Addict Med. 2023. PMID: 37788622 Free PMC article.
Mixed amphetamine salts-extended release (MAS-ER) as a behavioral treatment augmentation strategy for cocaine use disorder: A randomized clinical trial.
Carpenter KM, Choi CJ, Basaraba C, Pavlicova M, Brooks DJ, Brezing CA, Bisaga A, Nunes EV, Mariani JJ, Levin FR. Carpenter KM, et al. Among authors: nunes ev. Exp Clin Psychopharmacol. 2024 Feb;32(1):112-127. doi: 10.1037/pha0000676. Epub 2023 Sep 21. Exp Clin Psychopharmacol. 2024. PMID: 37732961 Clinical Trial.
321 results